Parameter estimations from SARS-CoV-2 electrochemical interactions Ashwin Ramanujam, Gerardine G. Botte View Original Artcle sciencedirect.com Highlights Characterized electrochemical SARS-CoV-2 interaction using CV and LSV techniques.
Pioneering Technology Revolutionary Saliva-Based HIV Testing Evirotech is at the forefront of medical innovation with our groundbreaking saliva-based HIV-I testing. Our proprietary sensor technology marks
Trends Around the World At the beginning of October, the global COVID-19 infection and mortality data was on the upswing again. A new wave began
Low Booster Uptake Common Concern A review of COVID-19 news stories this year reveals consistent concern over relatively low COVID-19 vaccine booster uptake among the
Medical Device Development Is Like Mountain Climbing In July 2020, EviroTECH founder and chief technology officer Dr. Gerardine Botte knew her team had developed something
We all remember how the world shut down in March 2020 due to the Coronavirus outbreak and awful pandemic that followed. Lives were lost, businesses
EviroTECH’S Story The story of the founding of EviroTECH is one of serendipity, innovation, and collaboration. A compelling purpose—the global health emergency created by the
Think the Need for COVID Testing is Over? Think Again. Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a strain of coronavirus that causes
Experience the future of HIV-I diagnosis – simpler, faster, and more accessible than ever before.
